Drugs / ABBV-711
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07241039 | Nov 2025 → Apr 2029 expected | squamous cell carcinoma | AbbVie | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABBV-711 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07241039 ↗ |
| Route | Oral | “Oral Tablet” NCT07241039 ↗ |